EUCRATES BIOMEDICAL ACQU COR's ticker is EUCR and the CUSIP is G3141W106. A total of 5 filers reported holding EUCRATES BIOMEDICAL ACQU COR in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $728 | +1.5% | 71,773 | 0.0% | 0.17% | -21.7% |
| Q4 2022 | $717 | -99.9% | 71,773 | 0.0% | 0.22% | +3.3% |
| Q3 2022 | $719,000 | +1.3% | 71,773 | 0.0% | 0.21% | +12.3% |
| Q2 2022 | $710,000 | +0.6% | 71,773 | 0.0% | 0.19% | +12.0% |
| Q1 2022 | $706,000 | +0.7% | 71,773 | 0.0% | 0.17% | +5.7% |
| Q4 2021 | $701,000 | +7.8% | 71,773 | +8.0% | 0.16% | -13.7% |
| Q3 2021 | $650,000 | – | 66,463 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SkyView Investment Advisors, LLC | 71,773 | $717 | 0.22% |
| EcoR1 Capital, LLC | 200,000 | $1,998,000 | 0.06% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| UBS Group AG | 3,483 | $34,795 | 0.00% |
| Tower Research Capital LLC (TRC) | 657 | $7 | 0.00% |
| DEUTSCHE BANK AG\ | 21,923 | $219,011 | 0.00% |